Juvenile myasthenia gravis: A twenty-year experience

Diana Castro, Samir Derisavifard, Mariam Anderson, Medrith Greene, Susan Iannaccone

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Juvenile myasthenia gravis (JMG) is an antibody-mediated autoimmune disorder of the neuromuscular junction, at the postsynaptic end plate. JMG presents with fluctuating skeletal muscle weakness and fatigue before the age of 18 years. Very frequently JMG presents with the involvement of the oculomotor muscles, with or without generalized involvement. METHODS:: We performed a retrospective chart review of patients diagnosed with myasthenia in the pediatric neuromuscular clinics at UT Southwestern, between 1990 and 2010. Osserman classification and the response to therapy scale of Millichap and Dodge were used to compare each patientÊs severity of myasthenia and responsiveness to drugs before the surgery as a baseline and at the last visit, after thymectomy. RESULTS:: Fifty-eight patients were included; 29 (50%) were African American, and 34 (58.6%) were female. Age of onset was 11 months to 17 years, and 38 patients (65%) presented as generalized myasthenia gravis. Forty-nine patients (84%) were acetylcholine receptor antibody (AchR-Ab) positive. Of the 32 to undergo thymectomy, 19 subjects (59%) experienced an improved response to B level on the Myasthenia Scale of Millichap and Dodge (good improvement, both objective and subjective, but continuation of drug therapy required in the same or lower dosage) and 75% experienced a drop in Osserman classification by at least 1. Of the 8 individuals who did not show improvement after thymectomy, 4 subjects (50%) underwent repeat thymectomy. They had initially less invasive fluoroscopic or thoracoscopic procedure. Thymic hyperplasia was found in 7 patients (21%) and thymoma in 2. CONCLUSIONS:: Thymectomy was well tolerated by this group of children. There was clinical improvement after thymectomy in two thirds of the AchR-Ab-positive generalized myasthenia gravis patients. Thymic pathology was seen in less than one third of the patients who underwent thymectomy, with thymic hyperplasia being common. Further studies are necessary to determine whether thymectomy is indicated for all children with generalized JMG. More information about the immunologic, genetic, and molecular differences between patients may determine the best treatment for individual patients. [-] [-] [-] [-] [-] [-] [-].

Original languageEnglish (US)
Pages (from-to)95-102
Number of pages8
JournalJournal of Clinical Neuromuscular Disease
Volume14
Issue number3
DOIs
StatePublished - Mar 2013

Fingerprint

Myasthenia Gravis
Thymectomy
Thymus Hyperplasia
Cholinergic Receptors
Antibodies
Oculomotor Muscles
Neuromuscular Junction Diseases
Muscle Fatigue
Thymoma
Muscle Weakness
Age of Onset
African Americans
Molecular Biology
Skeletal Muscle
Pediatrics
Pathology
Drug Therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Juvenile myasthenia gravis : A twenty-year experience. / Castro, Diana; Derisavifard, Samir; Anderson, Mariam; Greene, Medrith; Iannaccone, Susan.

In: Journal of Clinical Neuromuscular Disease, Vol. 14, No. 3, 03.2013, p. 95-102.

Research output: Contribution to journalArticle

Castro, Diana ; Derisavifard, Samir ; Anderson, Mariam ; Greene, Medrith ; Iannaccone, Susan. / Juvenile myasthenia gravis : A twenty-year experience. In: Journal of Clinical Neuromuscular Disease. 2013 ; Vol. 14, No. 3. pp. 95-102.
@article{05912573c7384a22b993c101fe61b4c7,
title = "Juvenile myasthenia gravis: A twenty-year experience",
abstract = "Juvenile myasthenia gravis (JMG) is an antibody-mediated autoimmune disorder of the neuromuscular junction, at the postsynaptic end plate. JMG presents with fluctuating skeletal muscle weakness and fatigue before the age of 18 years. Very frequently JMG presents with the involvement of the oculomotor muscles, with or without generalized involvement. METHODS:: We performed a retrospective chart review of patients diagnosed with myasthenia in the pediatric neuromuscular clinics at UT Southwestern, between 1990 and 2010. Osserman classification and the response to therapy scale of Millichap and Dodge were used to compare each patient{\^E}s severity of myasthenia and responsiveness to drugs before the surgery as a baseline and at the last visit, after thymectomy. RESULTS:: Fifty-eight patients were included; 29 (50{\%}) were African American, and 34 (58.6{\%}) were female. Age of onset was 11 months to 17 years, and 38 patients (65{\%}) presented as generalized myasthenia gravis. Forty-nine patients (84{\%}) were acetylcholine receptor antibody (AchR-Ab) positive. Of the 32 to undergo thymectomy, 19 subjects (59{\%}) experienced an improved response to B level on the Myasthenia Scale of Millichap and Dodge (good improvement, both objective and subjective, but continuation of drug therapy required in the same or lower dosage) and 75{\%} experienced a drop in Osserman classification by at least 1. Of the 8 individuals who did not show improvement after thymectomy, 4 subjects (50{\%}) underwent repeat thymectomy. They had initially less invasive fluoroscopic or thoracoscopic procedure. Thymic hyperplasia was found in 7 patients (21{\%}) and thymoma in 2. CONCLUSIONS:: Thymectomy was well tolerated by this group of children. There was clinical improvement after thymectomy in two thirds of the AchR-Ab-positive generalized myasthenia gravis patients. Thymic pathology was seen in less than one third of the patients who underwent thymectomy, with thymic hyperplasia being common. Further studies are necessary to determine whether thymectomy is indicated for all children with generalized JMG. More information about the immunologic, genetic, and molecular differences between patients may determine the best treatment for individual patients. [-] [-] [-] [-] [-] [-] [-].",
author = "Diana Castro and Samir Derisavifard and Mariam Anderson and Medrith Greene and Susan Iannaccone",
year = "2013",
month = "3",
doi = "10.1097/CND.0b013e318253a48e",
language = "English (US)",
volume = "14",
pages = "95--102",
journal = "Journal of Clinical Neuromuscular Disease",
issn = "1522-0443",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Juvenile myasthenia gravis

T2 - A twenty-year experience

AU - Castro, Diana

AU - Derisavifard, Samir

AU - Anderson, Mariam

AU - Greene, Medrith

AU - Iannaccone, Susan

PY - 2013/3

Y1 - 2013/3

N2 - Juvenile myasthenia gravis (JMG) is an antibody-mediated autoimmune disorder of the neuromuscular junction, at the postsynaptic end plate. JMG presents with fluctuating skeletal muscle weakness and fatigue before the age of 18 years. Very frequently JMG presents with the involvement of the oculomotor muscles, with or without generalized involvement. METHODS:: We performed a retrospective chart review of patients diagnosed with myasthenia in the pediatric neuromuscular clinics at UT Southwestern, between 1990 and 2010. Osserman classification and the response to therapy scale of Millichap and Dodge were used to compare each patientÊs severity of myasthenia and responsiveness to drugs before the surgery as a baseline and at the last visit, after thymectomy. RESULTS:: Fifty-eight patients were included; 29 (50%) were African American, and 34 (58.6%) were female. Age of onset was 11 months to 17 years, and 38 patients (65%) presented as generalized myasthenia gravis. Forty-nine patients (84%) were acetylcholine receptor antibody (AchR-Ab) positive. Of the 32 to undergo thymectomy, 19 subjects (59%) experienced an improved response to B level on the Myasthenia Scale of Millichap and Dodge (good improvement, both objective and subjective, but continuation of drug therapy required in the same or lower dosage) and 75% experienced a drop in Osserman classification by at least 1. Of the 8 individuals who did not show improvement after thymectomy, 4 subjects (50%) underwent repeat thymectomy. They had initially less invasive fluoroscopic or thoracoscopic procedure. Thymic hyperplasia was found in 7 patients (21%) and thymoma in 2. CONCLUSIONS:: Thymectomy was well tolerated by this group of children. There was clinical improvement after thymectomy in two thirds of the AchR-Ab-positive generalized myasthenia gravis patients. Thymic pathology was seen in less than one third of the patients who underwent thymectomy, with thymic hyperplasia being common. Further studies are necessary to determine whether thymectomy is indicated for all children with generalized JMG. More information about the immunologic, genetic, and molecular differences between patients may determine the best treatment for individual patients. [-] [-] [-] [-] [-] [-] [-].

AB - Juvenile myasthenia gravis (JMG) is an antibody-mediated autoimmune disorder of the neuromuscular junction, at the postsynaptic end plate. JMG presents with fluctuating skeletal muscle weakness and fatigue before the age of 18 years. Very frequently JMG presents with the involvement of the oculomotor muscles, with or without generalized involvement. METHODS:: We performed a retrospective chart review of patients diagnosed with myasthenia in the pediatric neuromuscular clinics at UT Southwestern, between 1990 and 2010. Osserman classification and the response to therapy scale of Millichap and Dodge were used to compare each patientÊs severity of myasthenia and responsiveness to drugs before the surgery as a baseline and at the last visit, after thymectomy. RESULTS:: Fifty-eight patients were included; 29 (50%) were African American, and 34 (58.6%) were female. Age of onset was 11 months to 17 years, and 38 patients (65%) presented as generalized myasthenia gravis. Forty-nine patients (84%) were acetylcholine receptor antibody (AchR-Ab) positive. Of the 32 to undergo thymectomy, 19 subjects (59%) experienced an improved response to B level on the Myasthenia Scale of Millichap and Dodge (good improvement, both objective and subjective, but continuation of drug therapy required in the same or lower dosage) and 75% experienced a drop in Osserman classification by at least 1. Of the 8 individuals who did not show improvement after thymectomy, 4 subjects (50%) underwent repeat thymectomy. They had initially less invasive fluoroscopic or thoracoscopic procedure. Thymic hyperplasia was found in 7 patients (21%) and thymoma in 2. CONCLUSIONS:: Thymectomy was well tolerated by this group of children. There was clinical improvement after thymectomy in two thirds of the AchR-Ab-positive generalized myasthenia gravis patients. Thymic pathology was seen in less than one third of the patients who underwent thymectomy, with thymic hyperplasia being common. Further studies are necessary to determine whether thymectomy is indicated for all children with generalized JMG. More information about the immunologic, genetic, and molecular differences between patients may determine the best treatment for individual patients. [-] [-] [-] [-] [-] [-] [-].

UR - http://www.scopus.com/inward/record.url?scp=84875420622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875420622&partnerID=8YFLogxK

U2 - 10.1097/CND.0b013e318253a48e

DO - 10.1097/CND.0b013e318253a48e

M3 - Article

C2 - 23492460

AN - SCOPUS:84875420622

VL - 14

SP - 95

EP - 102

JO - Journal of Clinical Neuromuscular Disease

JF - Journal of Clinical Neuromuscular Disease

SN - 1522-0443

IS - 3

ER -